Jasper Therapeutics Inc Sustainability Reports
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for diseases driven by mast cells and stem cells, including chronic urticaria and lower to intermediate risk myelodysplastic syndrome.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00QPZNPB4
1 reports from 2023 to 2023
Company Profile
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for diseases driven by mast cells and stem cells, including chronic urticaria and lower to intermediate risk myelodysplastic syndrome.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
